{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:03:48Z","timestamp":1792029828296,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peripheral artery disease (PAD) is a major cause of acute and chronic illness, with extremely poor prognosis that remains underdiagnosed and undertreated. Trimethylamine-N-Oxide (TMAO), a gut derived metabolite, has been associated with atherosclerotic burden. We determined plasma levels of TMAO by mass spectrometry and evaluated their association with PAD severity and prognosis. 262 symptomatic PAD patients (mean age 70 years, 87% men) categorized in intermittent claudication (IC, n\u2009=\u2009147) and critical limb ischemia (CLI, n\u2009=\u2009115) were followed-up for a mean average of 4 years (min 1-max 102 months). TMAO levels were increased in CLI compared to IC (P\u2009&lt;\u20090.001). Receiver operating characteristic (ROC) curves for severity (CLI) rendered a cutoff of 2.26\u2009\u00b5mol\/L for TMAO (62% sensitivity, 76% specificity). Patients with TMAO &gt;\u20092.26\u2009\u00b5mol\/L exhibited higher risk of cardiovascular death (sub-hazard ratios\u2009\u22652, P\u2009&lt;\u20090.05) that remained significant after adjustment for confounding factors. TMAO levels were associated to disease severity and CV-mortality in our cohort, suggesting an improvement of PAD prognosis with the measurement of TMAO. Overall, our results indicate that the intestinal bacterial function, together with the activity of key hepatic enzymes for TMA oxidation (FMO3) and renal function, should be considered when designing therapeutic strategies to control gut-derived metabolites in vascular patients.<\/jats:p>","DOI":"10.1038\/s41598-019-52082-z","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:29:48Z","timestamp":1572467388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Carmen","family":"Roncal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mart\u00ednez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Orbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-7401","authenticated-orcid":false,"given":"Alejandro","family":"Fernandez-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goren","family":"Saenz-Pipaon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ugarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Estella-Hermoso de Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2094-264X","authenticated-orcid":false,"given":"Jose A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Fern\u00e1ndez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Fern\u00e1ndez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julen","family":"Oyarzabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Paramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"52082_CR1","doi-asserted-by":"crossref","unstructured":"Morley, R. L., Sharma, A., Horsch, A. D. & Hinchliffe, R. J. Peripheral artery disease. BMJ 360, j5842, (2018).","DOI":"10.1136\/bmj.j5842"},{"key":"52082_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2017.12.031","volume":"270","author":"JK Stock","year":"2018","unstructured":"Stock, J. K. The challenge of peripheral arterial disease: How do we improve outcome? Atherosclerosis 270, 196\u2013198 (2018).","journal-title":"Atherosclerosis"},{"key":"52082_CR3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1161\/CIRCULATIONAHA.116.023513","volume":"133","author":"S Kinlay","year":"2016","unstructured":"Kinlay, S., Michel, T. & Leopold, J. A. The Future of Vascular Biology and Medicine. Circulation 133, 2603\u20139 (2016).","journal-title":"Circulation"},{"key":"52082_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13668-018-0252-z","volume":"7","author":"C Kanitsoraphan","year":"2018","unstructured":"Kanitsoraphan, C., Rattanawong, P., Charoensri, S. & Senthong, V. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality. Curr. Nutr. Rep. 7, 207\u2013213 (2018).","journal-title":"Curr. Nutr. Rep."},{"key":"52082_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"52082_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WHW Tang","year":"2013","unstructured":"Tang, W. H. W. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575\u201384 (2013).","journal-title":"N. Engl. J. Med."},{"key":"52082_CR7","doi-asserted-by":"crossref","first-page":"e002816","DOI":"10.1161\/JAHA.115.002816","volume":"5","author":"V Senthong","year":"2016","unstructured":"Senthong, V. et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. J. Am. Heart Assoc. 5, e002816 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"52082_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","volume":"37","author":"SH Zeisel","year":"2017","unstructured":"Zeisel, S. H. & Warrier, M. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease. Annu. Rev. Nutr. 37, 157\u2013181 (2017).","journal-title":"Annu. Rev. Nutr."},{"key":"52082_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.amjcard.2016.07.071","volume":"118","author":"Q Fu","year":"2016","unstructured":"Fu, Q. et al. Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease. Am. J. Cardiol. 118, 1311\u20131315 (2016).","journal-title":"Am. J. Cardiol."},{"key":"52082_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2018.04.015","volume":"273","author":"C Bogiatzi","year":"2018","unstructured":"Bogiatzi, C. et al. Metabolic products of the intestinal microbiome and extremes of atherosclerosis. Atherosclerosis 273, 91\u201397 (2018).","journal-title":"Atherosclerosis"},{"key":"52082_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u201385 (2013).","journal-title":"Nat. Med."},{"key":"52082_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell 165, 111\u2013124 (2016).","journal-title":"Cell"},{"key":"52082_CR13","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.jacc.2016.03.546","volume":"67","author":"V Senthong","year":"2016","unstructured":"Senthong, V. et al. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden. J. Am. Coll. Cardiol. 67, 2620\u20138 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"52082_CR14","doi-asserted-by":"crossref","first-page":"e004237","DOI":"10.1161\/JAHA.116.004237","volume":"5","author":"V Senthong","year":"2016","unstructured":"Senthong, V. et al. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease. J. Am. Heart Assoc. 5, e004237 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"52082_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng, J. et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed. Pharmacother. 97, 941\u2013947 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"52082_CR16","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jth.14234","volume":"16","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J. Thromb. Haemost. 16, 1857\u20131872 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"52082_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep26745","volume":"6","author":"E Randrianarisoa","year":"2016","unstructured":"Randrianarisoa, E. et al. Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans. Sci. Rep. 6, 26745 (2016).","journal-title":"Sci. Rep."},{"key":"52082_CR18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell 163, 1585\u201395 (2015).","journal-title":"Cell"},{"key":"52082_CR19","doi-asserted-by":"publisher","first-page":"1700299","DOI":"10.1002\/mnfr.201700299","volume":"62","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. The Effect of Different l -Carnitine Administration Routes on the Development of Atherosclerosis in ApoE Knockout Mice. Mol. Nutr. Food Res. 62, 1700299 (2018).","journal-title":"Mol. Nutr. Food Res."},{"key":"52082_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","volume":"243","author":"DM Mueller","year":"2015","unstructured":"Mueller, D. M. et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis 243, 638\u201344 (2015).","journal-title":"Atherosclerosis"},{"key":"52082_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.jrn.2015.02.006","volume":"25","author":"GA Kaysen","year":"2015","unstructured":"Kaysen, G. A. et al. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J. Ren. Nutr. 25, 351\u20136 (2015).","journal-title":"J. Ren. Nutr."},{"key":"52082_CR22","doi-asserted-by":"publisher","first-page":"e003970","DOI":"10.1161\/JAHA.116.003970","volume":"5","author":"KA Meyer","year":"2016","unstructured":"Meyer, K. A. et al. Microbiota\u2010Dependent Metabolite Trimethylamine N\u2010Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA). J. Am. Heart Assoc. 5, e003970 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"52082_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","volume":"92","author":"JAP Tomlinson","year":"2017","unstructured":"Tomlinson, J. A. P. & Wheeler, D. C. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease. Kidney Int. 92, 809\u2013815 (2017).","journal-title":"Kidney Int."},{"key":"52082_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett, B. J. et al. Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation. Cell Metab. 17, 49\u201360 (2013).","journal-title":"Cell Metab."},{"key":"52082_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao, J. et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun. 6, 6498 (2015).","journal-title":"Nat. Commun."},{"key":"52082_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WHWHW Tang","year":"2015","unstructured":"Tang, W. H. W. H. W. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116, 448\u2013455 (2015).","journal-title":"Circ. Res."},{"key":"52082_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/ASN.2014111063","volume":"27","author":"JR Stubbs","year":"2016","unstructured":"Stubbs, J. R. et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J. Am. Soc. Nephrol. 27, 305\u201313 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"52082_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01387-y","volume":"7","author":"K-Y Xu","year":"2017","unstructured":"Xu, K.-Y. et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci. Rep. 7, 1445 (2017).","journal-title":"Sci. Rep."},{"key":"52082_CR29","doi-asserted-by":"publisher","first-page":"1700363","DOI":"10.1002\/mnfr.201700363","volume":"61","author":"R Kr\u00fcger","year":"2017","unstructured":"Kr\u00fcger, R. et al. Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions. Mol. Nutr. Food Res. 61, 1700363 (2017).","journal-title":"Mol. Nutr. Food Res."},{"key":"52082_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/cclm-2016-0374","volume":"55","author":"T K\u00fchn","year":"2017","unstructured":"K\u00fchn, T. et al. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year. Clin. Chem. Lab. Med. 55, 261\u2013268 (2017).","journal-title":"Clin. Chem. Lab. Med."},{"key":"52082_CR31","doi-asserted-by":"crossref","first-page":"e004947","DOI":"10.1161\/JAHA.116.004947","volume":"6","author":"Y Heianza","year":"2017","unstructured":"Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M. & Qi, L. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta\u2010Analysis of Prospective Studies. J. Am. Heart Assoc. 6, e004947 (2017).","journal-title":"Studies. J. Am. Heart Assoc."},{"key":"52082_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jvs.2014.09.002","volume":"61","author":"E Martinez-Aguilar","year":"2015","unstructured":"Martinez-Aguilar, E. et al. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease. J Vasc Surg 61, 428\u2013435 (2015).","journal-title":"J Vasc Surg"},{"key":"52082_CR33","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jvs.2017.04.056","volume":"66","author":"E Martinez-Aguilar","year":"2017","unstructured":"Martinez-Aguilar, E. et al. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease. J. Vasc. Surg. 66, 1527\u20131533 (2017).","journal-title":"J. Vasc. Surg."},{"key":"52082_CR34","first-page":"152","volume":"31","author":"M Marcos Jubilar","year":"2019","unstructured":"Marcos Jubilar, M. et al. Analysis of monocitary subpopulations in relation to cardiovascular risk factors. Clin. Investig. Arterioscler. 31, 152\u2013159 (2019).","journal-title":"Clin. Investig. Arterioscler."},{"key":"52082_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchromb.2016.10.017","volume":"1038","author":"HM Awwad","year":"2016","unstructured":"Awwad, H. M., Geisel, J. & Obeid, R. Determination of trimethylamine, trimethylamine N-oxide, and taurine in human plasma and urine by UHPLC\u2013MS\/MS technique. J. Chromatogr. B 1038, 12\u201318 (2016).","journal-title":"J. Chromatogr. B"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52082-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:12:35Z","timestamp":1671289955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52082"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52082-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15580"}}